viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Filgrastim
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Accofil
Belgia, Saksamaa, Suurbritannia
Biocilin
Mehhiko
Duperan
Tšiili
Filgen
Argentiina
Foltran
Tšiili
Granulokine
Itaalia, Kreeka
Hebervital
Kolumbia
Inmunef
Kolumbia
Leucosos
Kolumbia
Lioplim
Tšiili
Neupogen
Ameerika ühendriigid, Austria, Belgia, Hispaania, Holland, Horvaatia, Lõuna Aafrika Vabariik, Poola, Portugal, Prantsusmaa, Rootsi, Sloveenia, Soome, Suurbritannia, Sveits, Taani, Türgi
Neutromax
Argentiina
Neutropine
Argentiina
Nivestim
Belgia, Holland, Norra, Prantsusmaa, Saksamaa, Suurbritannia
Ratiograstim
Austria, Rootsi, Saksamaa, Suurbritannia
Tevagrastim
Holland, Norra, Rootsi, Saksamaa, Suurbritannia, Sveits
Viited : Filgrastim
tüüp
avaldamine
99
ajaleht
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104
ajaleht
Hall PD, Yui D, Lyons S, Bosso JA.
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 185-189.
182
ajaleht
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244
ajaleht
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269
ajaleht
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128
Labor
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3249
ajaleht
Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256
ajaleht
Burnett B, Radic I.
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
EJHP 2011 ; 17, 5: 49-56.
3474
Labor
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3618
Labor
Filgrastim (Neupogen®) - Summary of Product Characteristics
Amgen 2014
3828
plakat
Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829
plakat
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055
ajaleht
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380
Labor
Posaconazole (Noxafil®) - Summary of Product Characteristics
Merck Sharp & Dohme Limited 2019
4471
Labor
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4521
ajaleht
Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
4650
Labor
Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
Advanz Pharma 2021
Mentions Légales
